Sayre Therapeutics
Bangalore
About Sayre Therapeutics
At Sayre Therapeutics, They focus on bringing hitherto unavailable novel medicines, drug-delivery devices, companion diagnostics and diagnostic imaging agents to medical oncologists, surgical oncologists, radiation oncologists, interventional radiologists and rheumatologists.These include, but are not limited to, small molecules, recombinant proteins,monoclonal antibodies (mAbs),drug-delivery devices and diagnostics in Oncology and Immunology.Our business model encompasses Global access / early access programs, Named Patient programs and securing product registrations for exclusive commercial distribution in South Asia.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $9.0M
- Last round: Series Unknown (Sep 2017)
- Website: sayretherapeutics.com
- Phone: +918041137692
Industries & Categories
Biotechnology, Health Diagnostics, Medical Device, Oncology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/sayre-therapeutics-106250 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.